Geron Corp (NASDAQ:GERN)

1.59
Delayed Data
As of Sep 13
 0.00 / 0.00%
Today’s Change
0.95
Today|||52-Week Range
6.66
+59.00%
Year-to-Date
No recent news for Geron Corp.

Today’s Trading

Previous close1.59
Today’s open1.60
Day’s range1.55 - 1.64
Volume4,282
Average volume (3 months)1,613,794
Market cap$298.7M
Data as of 4:00pm ET, 09/13/2019

Growth & Valuation

Earnings growth (last year)+14.94%
Earnings growth (this year)-185.33%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+0.09%
P/E ratioNM
Price/Sales165.58
Price/Book1.66

Competitors

 Today’s
change
Today’s
% change
UBXUnity Biotechnology ...0.000.00%
ADMAADMA Biologics Inc+0.18+3.53%
PDLIPDL BioPharma Inc-0.02-0.89%
LJPCLa Jolla Pharmaceuti...+0.08+0.73%
Data as of 9:32am ET, 09/16/2019

Financials

Next reporting dateNovember 11, 2019
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$1.1M
Annual profit (last year)-$27.0M
Net profit margin-2,534.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
John A. Scarlett
Chief Operating Officer &
Executive Vice President
Andrew J. Grethlein
Corporate headquarters
Menlo Park, California

Forecasts